Collagen Lattice Model, Populated with Heterogeneous Cancer-Associated Fibroblasts, Facilitates Advanced Reconstruction of Pancreatic Cancer Microenvironment
Authors:
- Xiaoyu SongXSXiaoyu Song
- Yuma NihashiYNYuma Nihashi
- Yukiko ImaiYIYukiko Imai
- Nobuhito MoriNMNobuhito Mori
- Noritaka KagayaNKNoritaka Kagaya
- Hikaru SuenagaHSHikaru Suenaga
- Kazuo Shin-YaKSKazuo Shin-Ya
- Masamichi YamamotoMYMasamichi Yamamoto
- Daiki SetoyamaDSDaiki Setoyama
- Yuya KunisakiYKYuya Kunisaki
- Yasuyuki S. KidaYKYasuyuki S. Kida
Open Access
- 27 March 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (7) , 3740
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a solid-tumor malignancy. To enhance the treatment landscape of PDAC, a 3D model optimized for rigorous drug screening is essential. Within the PDAC tumor microenvironment, a dense stroma comprising a large extracellular matrix and cancer-associated fibroblasts (CAFs) is well-known for its vital role in modulating tumor growth, cellular heterogeneity, bidirectional paracrine signaling, and chemoresistance. In this study, we employed a fibroblast-populated collagen lattice (FPCL) modeling approach that has the ability to replicate fibroblast contractility in the collagenous matrix to build dense stroma. This FPCL model allows CAF differentiation by facilitating multifaceted cell–cell interactions between cancer cells and CAFs, with the differentiation further influenced by mechanical forces and hypoxia carried within the 3D structure. Our FPCL models displayed hallmark features, including ductal gland structures and differentiated CAFs with spindle shapes. Through morphological explorations alongside in-depth transcriptomic and metabolomic profiling, we identified substantial molecular shifts from the nascent to mature model stages and potential metabolic biomarkers, such as proline. The initial pharmacological assays highlighted the effectiveness of our FPCL model in screening for improved therapeutic strategies. In conclusion, our PDAC modeling platform mirrors complex tumor microenvironmental dynamics and offers an unparalleled perspective for therapeutic exploration.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP23K13919, JP22ama121050j0001, JPMJSP2124)
- Japan Agency for Medical Research and Development (JP23K13919, JP22ama121050j0001, JPMJSP2124)
- Japan Science and Technology Agency (JP23K13919, JP22ama121050j0001, JPMJSP2124)
This publication has 57 references indexed in Scilit:
- Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter studyCancer Medicine, 2022
- Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancerCancer Cell, 2022
- Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblastsAdvanced Drug Delivery Reviews, 2021
- Adipose‐derived mesenchymal stem cells differentiate into pancreatic cancer‐associated fibroblasts in vitroFEBS Open Bio, 2020
- CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic CancerTrends in Cancer, 2019
- Comparative study of the therapeutic effect of Doxorubicin and Resveratrol combination on 2D and 3D (spheroids) cell culture modelsInternational Journal of Pharmaceutics, 2018
- Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinomaCancer Medicine, 2017
- Spherical Cancer Models in Tumor BiologyNeoplasia, 2015
- Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell modelMolecular and Cellular Biochemistry, 2013
- Mechanical Stress Is Required for High-Level Expression of Connective Tissue Growth FactorExperimental Cell Research, 2002